Relapse Incidence
Relapse Incidence is a clinical epidemiological metric that quantifies the proportion of transplant recipients who experience a recurrence of their underlying disease following a period of remission, typically after allogeneic hematopoietic stem cell transplantation.
733
Publications
44.4K
Citations
6.2K
Authors
1.8K
Institutions
Publications per year
2017–2026
225
Parents
733
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
Malcolm K. Brenner, D. Rill, Robert A. Krance et al. · The Lancet · 1993 · 920 citations
Medicine, Cell Biology, Hematology +10
1–5 of 733
6.2K
24
h-index
24
h-index
20
h-index
19
h-index
13
h-index
1–5 of 6.2K
1.8K

Sorbonne Université
Paris, France
27 h-index
160 publications
14.3K citations
Inserm
Paris, France
26 h-index
165 publications
9.1K citations

Sheba Medical Center
Ramat Gan, Israel
22 h-index
48 publications
2.4K citations
Hôpital Saint-Antoine
Paris, France
21 h-index
92 publications
5.2K citations
European Society for Blood and Marrow Transplantation
Paris, France
17 h-index
91 publications
8.4K citations
Assistance Publique – Hôpitaux de Paris
Paris, France
16 h-index
85 publications
4.2K citations
Hôpital Saint-Louis
Paris, France
15 h-index
33 publications
1.9K citations
Hospital Clínic de Barcelona
Barcelona, Spain
15 h-index
30 publications
2.2K citations
1–8 of 1.8K
TCT · 40 publications · 1.8K citations
26
h-index
19 publications · 3.1K citations
19
h-index
Repository · 31 publications · 1K citations
18
h-index
BJH · 20 publications · 1.1K citations
17
h-index
14 publications · 783 citations
14
h-index
1–5